EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Stroke and high-risk TIA outcomes with reduction of treatment duration when treatment initiated in emergency rooms (SHORTER-study)

Adel Alhazzani iD, Fahad S Alajlan, Ali M Alkhathaami, Fahmi Mohammed Al-Senani iD, Taim A Muayqil, Saeed A Alghamdi, Ammar AlKawi iD, Saeed AlZahrani, Majid Bakheet, Mohammed Aljohani, Nouran Taher, Abdulkarim Almutairi und 16 weitere

International Journal of Stroke · 2024

DOI: 10.1177/17474930241237120 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift International Journal of Stroke, 2024. Verfasst von Adel Alhazzani und 27 weiteren Autor:innen. Beteiligte Einrichtung: King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Clopidogrel, Emergency Service, Hospital, Ischemic Attack, Transient, Platelet Aggregation Inhibitors. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Following transient ischemic attack (TIA) and minor stroke, the risk of recurrent stroke can be significantly reduced with short-duration dual antiplatelet therapy (DAPT). We wish to investigate whether 10 days of DAPT is as effective as 21 days’ treatment. Study design: This is an open-label, randomized, parallel-group study comparing whether 10 days of DAPT treatment (ASA + clopidogrel) is non-inferior to 21 days of DAPT in patients with acute ischemic stroke (AIS) or high-risk TIA. In both groups, DAPT is started within 24 hours of symptom onset. This study is being conducted in approximately 15 study sites in the Kingdom of Saudi Arabia. The planned sample size is 1932. Outcomes: Non-inferiority of 10 days compared to 21 days of DAPT in the prevention of the composite endpoint of stroke and death at 90 days in AIS/TIA patients. The primary safety outcome is major intra-cranial and systemic hemorrhage. Study period: Enrolment started in the second quarter of 2023, and the completion of the study is expected in the fourth quarter of 2025.

Discussion

The trial is expected to show that 10 days of DAPT is non-inferior for the prevention of early recurrence of vascular events in patients with high-risk TIAs and minor strokes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClopidogrelEmergency Service, HospitalIschemic Attack, TransientPlatelet Aggregation InhibitorsStrokeAgedFemaleHumansMaleMiddle AgedAspirinDual Anti-Platelet TherapyIschemic StrokeSaudi ArabiaSecondary PreventionTime FactorsTreatment Outcome

Stichwörter der Autor:innen

Antiplatelet therapyAspirinTIAantithromboticminor strokestroke prevention

Substanzen

AspirinClopidogrelPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Neurology Unit, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • King Faisal Specialist Hospital & Research Center, Jeddah, Saudi Arabia.
  • King Fahad General Hospital, Ministry of Health, Jeddah, Saudi Arabia.

ORCID-Profile: Adel Alhazzani, Fahmi Mohammed Al-Senani, Ammar AlKawi

Zitieren

APA

Alhazzani, A., Alajlan, F. S., Alkhathaami, A. M., Al-Senani, F. M., Muayqil, T. A., Alghamdi, S. A., AlKawi, A., AlZahrani, S., Bakheet, M., Aljohani, M., Taher, N., Almutairi, A., AlQarni, M., Alsalman, S., Alqahtani, S. A., Almansour, N., Abukhamsin, L., Mouminah, A., Almodarra, N., …, & Shuaib, A. (2024). Stroke and high-risk TIA outcomes with reduction of treatment duration when treatment initiated in emergency rooms (SHORTER-study). International Journal of Stroke. https://doi.org/10.1177/17474930241237120

Vancouver

Alhazzani A, Alajlan FS, Alkhathaami AM, Al-Senani FM, Muayqil TA, Alghamdi SA, et al. Stroke and high-risk TIA outcomes with reduction of treatment duration when treatment initiated in emergency rooms (SHORTER-study). International Journal of Stroke. 2024. doi:10.1177/17474930241237120

BibTeX
@article{Alhazzani2024,
  author = {Alhazzani, Adel and Alajlan, Fahad S and Alkhathaami, Ali M and Al-Senani, Fahmi Mohammed and Muayqil, Taim A and Alghamdi, Saeed A and AlKawi, Ammar and AlZahrani, Saeed and Bakheet, Majid and Aljohani, Mohammed and Taher, Nouran and Almutairi, Abdulkarim and AlQarni, Mustafa and Alsalman, Sadiq and Alqahtani, Saeed A and Almansour, Nouf and Abukhamsin, Laila and Mouminah, Amr and Almodarra, Nehal and Mohamed, Gamal and Almodhy, Meshal and Albogumi, Eid and Alzawahmah, Mohamad and Alreshaid, Abdulrahman and Akhtar, Naveed and Hussain, Muhammad Shazam and Albers, Gregory W and Shuaib, Ashfaq},
  title = {Stroke and high-risk TIA outcomes with reduction of treatment duration when treatment initiated in emergency rooms (SHORTER-study)},
  journal = {International Journal of Stroke},
  year = {2024},
  doi = {10.1177/17474930241237120}
}
Kostenlos starten →